---
figid: PMC4689482__OR-35-02-0607-g01
figtitle: ARID1A mutation and anticancer agents on the PI3K/AKT pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4689482
filename: OR-35-02-0607-g01.jpg
figlink: /pmc/articles/PMC4689482/figure/f2-or-35-02-0607/
number: F2
caption: Effects of ARID1A mutation and anticancer agents on the PI3K/AKT pathway.
  ARID1A mutations frequently co-occur with mutations of PTEN and PIK3CA. PTEN mutation
  inactivates PTEN and PIK3CA mutation activates PI3K, which lead to stimulation of
  cell growth, proliferation and survival. Temsirolimus inhibits the PI3K/AKT/mTOR
  signaling pathway by binding to the mTORC1 complex (). Sorafenib is a multikinase
  inhibitor that targets the mitogen-activated protein kinase (MAPK) pathway, and
  also inhibits vascular endothelial growth factor receptor (VEGFR) and platelet-derived
  growth factor receptor (PDGFR).
papertitle: ARID1A gene mutation in ovarian and endometrial cancers (Review).
reftext: TAKASHI TAKEDA, et al. Oncol Rep. 2016 Feb;35(2):607-613.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9383261
figid_alias: PMC4689482__F2
figtype: Figure
redirect_from: /figures/PMC4689482__F2
ndex: ecddbf1e-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4689482__OR-35-02-0607-g01.html
  '@type': Dataset
  description: Effects of ARID1A mutation and anticancer agents on the PI3K/AKT pathway.
    ARID1A mutations frequently co-occur with mutations of PTEN and PIK3CA. PTEN mutation
    inactivates PTEN and PIK3CA mutation activates PI3K, which lead to stimulation
    of cell growth, proliferation and survival. Temsirolimus inhibits the PI3K/AKT/mTOR
    signaling pathway by binding to the mTORC1 complex (). Sorafenib is a multikinase
    inhibitor that targets the mitogen-activated protein kinase (MAPK) pathway, and
    also inhibits vascular endothelial growth factor receptor (VEGFR) and platelet-derived
    growth factor receptor (PDGFR).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KDR
  - FLT1
  - FLT4
  - PDGFRB
  - PDGFRA
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - NRAS
  - PTEN
  - BRAF
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ARID1A
  - MTOR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Temsirolimus
  - Cancer
  - Lung cancer
---
